Data as of .
ARKG vs BBP: which is really different?
ARKG and BBP hold 3% of their weight in the same names, and ARKG returned more over the year.
ETFIQ Off-Index Score: BBP scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
3% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, ARKG and BBP hold 3% of their money in the same securities at the same weight.
| Holding | ARKG | BBP |
|---|---|---|
| IONIS PHARMACEUTICALS INC | 1.60% | 1.48% |
| CRISPR THERAPEUTICS AG | 5.63% | 1.48% |
| Only in ARKG | Only in BBP |
|---|---|
| TWIST BIOSCIENCE CORP 9.63% | IMMUNITYBIO INC 4.83% |
| 10X GENOMICS INC-CLASS A 9.39% | APELLIS PHARMACEUTICALS INC 2.60% |
| TEMPUS AI INC-CL A 8.92% | KALVISTA PHARMACEUTICALS INC 2.53% |
| PERSONALIS INC 5.16% | MODERNA INC 2.50% |
| GUARDANT HEALTH INC 4.87% | IOVANCE BIOTHERAPEUTICS INC 2.45% |
| ABSCI CORP 4.76% | MIRUM PHARMACEUTICALS INC 2.40% |
| NATERA INC 4.25% | AXSOME THERAPEUTICS INC 2.25% |
| ILLUMINA INC 4.13% | KINIKSA PHARMACEUTICALS INTERNATIONAL PL 2.07% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Sep 21, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| ARKG | BBP | ARKG | BBP | ARKG | BBP | |
| 3 months | +40.1% | +15.3% | +37.9 pts | +13.1 pts | +42.6 pts | +17.8 pts |
| 6 months | +98.2% | +29.5% | +80.2 pts | +11.5 pts | +74.0 pts | +5.3 pts |
| 1 year | +87.1% | +47.5% | +70.6 pts | +30.9 pts | +65.4 pts | +25.7 pts |
| 3 years | +74.8% | +103.0% | −3.6 pts | +24.6 pts | −23.4 pts | +4.8 pts |
| Since launch | +174.6% | +304.4% | −186.8 pts | −56.6 pts | −504.0 pts | −371.1 pts |
| ARKG ARK Genomic Revolution ETF Holds 33 stocks in genomics and gene editing, 4% of its weight in S&P 500 companies | BBP Virtus Biotech ETF Holds 60 stocks in biotech, 12% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | ARK | Virtus |
| Theme | Genomics and gene editing | Biotech |
| In the S&P 500 | 3.5% | 12.4% |
| Active share vs the S&P 500 | 98.5% | 99.0% |
| In the Nasdaq-100 | 0.0% | 8.9% |
| Holdings | 33 | 60 |
| Top ten, share of the fund | 60.4% | 25.7% |
| Expense ratio | 0.75% | 0.34% |
| Fee for the differing part | 0.76% | 0.34% |
| Total return, 1 year | +87.1% | +47.5% |
| vs the S&P 500 | +70.6 pts | +30.9 pts |
| vs the Nasdaq-100 | +65.4 pts | +25.7 pts |
| Below its high | −53.8% | −5.5% |
| Net assets | $2.2bn | $59m |
ARKG in plain words
By weight, 4% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 60% of the fund across 33 positions, as published by its issuer for Sep 21, 2026. Over the year to Sep 18, 2026 the fund returned +87.1% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 70.6 pts. It sits 53.8% below its all-time high of Jan 20, 2021.
BBP in plain words
By weight, 12% of BBP's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 26% of the fund across 60 positions, as filed for Apr 30, 2026. Over the year to Sep 18, 2026 the fund returned +47.5% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 30.9 pts. It sits 5.5% below its all-time high of Aug 19, 2026.
Questions people ask
- Do ARKG and BBP hold the same stocks?
- By their latest filings, 3% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, ARKG or BBP?
- ARKG has 4% of its weight in S&P 500 names and BBP has 12%, so BBP differs more from the index.
- Which is cheaper, ARKG or BBP?
- ARKG charges 0.75% a year and BBP charges 0.34%, so BBP is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, ARKG against BBP, data as of Sep 18, 2026. https://etfiq.com/compare/themes/arkg-vs-bbp Free to use with attribution; the underlying files are at Open data.